Related Experiment Videos
Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia
1Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California, 90048, USA.
Cancer Genetics and Cytogenetics
|February 1, 1996
Abstract:
We report a patient with a history of leukopenia who developed acute myeloid leukemia (AML) FAB M2 and was successfully treated with induction and consolidation chemotherapy. She relapsed 7 months after initial diagnosis. Peripheral blood cells at relapse showed a t(12;15)(p13;q13), which has not been previously described in de novo or relapsed AML.